Abstract:BACKGROUND: Abnormal activation of the Wnt/β‐catenin signaling pathway is common and critical in the pathogenesis of digestive cancers. In this study, the authors investigated the promoter methylation of the dickkopf homolog 3 gene Dkk‐3 in these cancers and its prognostic significance in gastric cancer. METHODS: Dkk‐3 methylation was assessed in 173 patients with gastric cancers (including 104 patients who were followed for up to 4090 days) and in 128 patients with colorectal cancer. Cell growth was evaluated by using a colony‐formation assay. For survival analyses, the authors used Kaplan‐Meier plots, the log‐rank test, and Cox proportional regression. RESULTS: Dkk‐3 was silenced or down‐regulated in 12 of 17 gastric cancer cell lines (70.6%) and in 3 of 9 colon cancer cell lines (33.3%). The loss of gene expression was associated with promoter methylation, which could be restored by demethylating agents. Ectopic expression of Dkk‐3 suppressed colony formation. Moreover, methylation of Dkk‐3 was detected in 117 of 173 primary gastric tumors (67.6%) and in 67 of 128 colorectal tumors (52.3%). The clinical significance and the prognostic value of Dkk‐3 methylation also were examined in 104 gastric cancers and in 84 colorectal cancers. Multivariate analysis indicated that Dkk‐3 methylation was associated significantly and independently with poor disease survival (relative risk, 2.534; 95% confidence interval, 1.54–4.17; P = .002) in gastric cancer, but not in colorectal cancer. Kaplan‐Meier survival curves revealed that patients who had Dkk‐3 methylated gastric cancers had a significantly shorter survival (median, 0.76 years) compared with patients who did not have Dkk‐3 methylation (median, 2.68 years; P < .0001; log‐rank test). CONCLUSIONS: Epigenetic silencing of the Dkk‐3 gene by promoter methylation was a common event in gastric cancer and was associated with a poor outcome in such patients. Cancer 2009. © 2008 American Cancer Society.

Aberrant methylation and expression of WWOX gene in gastric cardia adenocarcinoma

Relationship between promoter methylation status and protein expression of the wwox gene in hepatocellular carcinoma

Remote Modulation of WWOX by an Intronic Variant Associated with Survival of Chinese Gastric Cancer Patients.

CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer.

Methylation Ofgata-4Andgata-5and Development of Sporadic Gastric Carcinomas

Down-regulated C4orf19 Confers Poor Prognosis in Colon Adenocarcinoma Identified by Gene Co-Expression Network.

Loss of transcription factor GATA 4/ 5 by hypermethylation correlated with progression of gastric carcinomas

Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.

METHYLATION OF GENE E-CADHERIN AND ITS EXPRESSION IN GASTRIC CARCINOMAS

Expression of WWOX Protein in Non-Small Cell Lung Cancer and Its Significance

Loss of WWOX expression in human extrahepatic cholangiocarcinoma

Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma

Expressions and Clinical Significances of Wnt5a and MMP14 in Gastric Cancer

Prognostic Significance of Aberrant Gene Methylation in Gastric Cancer.

Aberrant Methylation of the CpG Island of HLTF Gene in Gastric Cardia Adenocarcinoma and Dysplasia

Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer.

Expression of COX-2 Protein in Gastric Cardia Adenocarcinoma Tissue

XRCC1 Downregulated Through Promoter Hypermethylation is Involved in Human Gastric Carcinogenesis

Expression and Methylation Level of Promoter Regions of DR4 and DR5 in Gastric Cancer

Promoter methylation of the Wnt/β-catenin signaling antagonist<i>Dkk-3</i>is associated with poor survival in gastric cancer

Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures